Metformin as a Neuroprotective Therapy for Glaucoma

Abroad (travel likely)RecruitingPHASE2

Conditions

Glaucoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

HKU Eye Centre, Wong Chuk Hang, Hong Kong
Contact: Study coordinator (Gilda LAI) · (852)3910-2672

Study leads

Christopher LEUNG, MD
Principal Investigator
The University of Hong Kong

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Phase 2/Phase 3 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant

Glaucoma

Abroad (travel likely)RecruitingPHASE2, PHASE3

Grand Junction, United States · Oklahoma City, United States

Evaluation of BRUDYGLAUCO (DHA + Citicoline) in Patients With Glaucoma

Glaucoma · Primary Open Angle Glaucoma (POAG) · Neuroprotection

Abroad (travel likely)Recruiting

Barcelona, Spain · Barcelona, Spain

Hydrus® Microstent New Enrollment Post-Approval Study

Primary Open Angle Glaucoma

Abroad (travel likely)Recruiting

Irvine, United States · Sacramento, United States

The Vizio Clinical Study

Refractory Glaucoma

Abroad (travel likely)Recruiting

Colonia Escalón, El Salvador